36
Clinical Conditions & Symptom Management: Heart Failure VNAA Blueprint for Excellence PATHWAY TO BEST PRACTICES VNAA Best Practices for Home Health

Clinical Conditions & Symptom Management: Heart Failure0104.nccdn.net/1_5/3ac/28b/021/HF-Blueprint-Guide-Final.pdf · Clinical Conditions & Symptom Management: Heart Failure VNAA

  • Upload
    others

  • View
    19

  • Download
    2

Embed Size (px)

Citation preview

Page 1: Clinical Conditions & Symptom Management: Heart Failure0104.nccdn.net/1_5/3ac/28b/021/HF-Blueprint-Guide-Final.pdf · Clinical Conditions & Symptom Management: Heart Failure VNAA

Clinical Conditions & Symptom Management: Heart Failure

VNAA Blueprint for Excellence PATHWAY TO BEST PRACTICES

VNAA Best Practices for Home Health

Presenter
Presentation Notes
Good morning I am pleased today to share with you the work that the VNAA members, academics, & leaders from the three accrediting bodies, have been involved with since July 2013. This is our second phase of the Blueprint for Excellence where the focus was now is on Hospice & Palliative Care. I am here to provide a preview of these best practices to answer any questions, & to get feedback on this work that we have done so far. I am joined by the co-chair of the work group, &rea Huertas, who has worked in home health, hospice & palliative care for over 22 years as an administrator & nurse. &rea worked the past 11years in New Hampshire with Central NH VNA & Hospice as their Hospice Director.  Currently, she is the Clinical Director at Christiana Care VNA in New Castle, DE.
Page 2: Clinical Conditions & Symptom Management: Heart Failure0104.nccdn.net/1_5/3ac/28b/021/HF-Blueprint-Guide-Final.pdf · Clinical Conditions & Symptom Management: Heart Failure VNAA

Definition A complex clinical syndrome that results from any structural or functional impairment of ventricular filling or ejection of blood. The cardinal manifestations of HF are dyspnea & fatigue, which may limit exercise tolerance, & fluid retention, which may lead to pulmonary &/or splanchnic congestion &/or peripheral edema (ACCF/AHA Guidelines, 2013).

2

Page 3: Clinical Conditions & Symptom Management: Heart Failure0104.nccdn.net/1_5/3ac/28b/021/HF-Blueprint-Guide-Final.pdf · Clinical Conditions & Symptom Management: Heart Failure VNAA

Why Heart Failure • High mortality, frequent hospitalizations & poor quality of life • More than 5 million individuals have HF & prevalence will continue to rise

as population ages (Yancy, 2013) • Pts. w/a primary diagnosis of HF account for 5.5% of pts. seen by home

health • Over 80% of home health pts. have 3 or more chronic conditions w/HF

often being 1 of those conditions

3

Page 4: Clinical Conditions & Symptom Management: Heart Failure0104.nccdn.net/1_5/3ac/28b/021/HF-Blueprint-Guide-Final.pdf · Clinical Conditions & Symptom Management: Heart Failure VNAA

VNAA Best Practices

1. Pts. w/diagnosis of HF should be assessed for risk of hospitalization 2. Non-pharmacological & pharmacological interventions for HF should be

addressed in systematic approach 3. Utilize evidence-based HF Disease Management program including

teaching tools to assure consistency in care & pt. teaching 4. Focus on helping pts. understand & retain information while developing

self-care competencies

4

Page 5: Clinical Conditions & Symptom Management: Heart Failure0104.nccdn.net/1_5/3ac/28b/021/HF-Blueprint-Guide-Final.pdf · Clinical Conditions & Symptom Management: Heart Failure VNAA

Critical Interventions/Actions – Intake Obtain following info. as part of intake process:

– H&P &/or hospital discharge summary – NYHA &/or ACCF (preferred) Classification & ejection fraction – Risk indicators for re-hospitalization & pt safety – Discharge/current medication – Any lab tests &/or ordered treatments – Teach-back readiness & teaching tools used by referral source – Staff concerns re: discharge & safety – Extent of family involvement; identified caregiver; pt. rep.

5

Page 6: Clinical Conditions & Symptom Management: Heart Failure0104.nccdn.net/1_5/3ac/28b/021/HF-Blueprint-Guide-Final.pdf · Clinical Conditions & Symptom Management: Heart Failure VNAA

Critical Interventions/Actions – Intake Call/speak to pt. on day of dc from facility to ask:

– Who is helping you at home? – Has your breathing changed since you got

home or have you had any chest pain? – Were all of your prescribed medications

obtained? Any questions about them? – Do you feel safe &/or do you need a visit

today/this evening? – Do you know who to call if your

symptoms change?

6

Page 7: Clinical Conditions & Symptom Management: Heart Failure0104.nccdn.net/1_5/3ac/28b/021/HF-Blueprint-Guide-Final.pdf · Clinical Conditions & Symptom Management: Heart Failure VNAA

Critical Interventions/Actions – Visit Planning

• Provide agency name & contact info. • Admit w/in 24 hours of facility discharge • Plan SN, Rehab & HHA schedule – Visit frequencies for weeks 1-4

– 3 RN visits the 1st week (frontloading) then 1-3 times/week (consider consecutive nursing visits for 2nd &/or 3rd )

– At least 1 in home visit in 1st week from each of ordered therapies, then 1-2 times/week

– Phone contact on days in between visits • Implement Tele-health by 2nd day • Physician follow-up/appt. made w/in 7-10 days of dc

7

Page 8: Clinical Conditions & Symptom Management: Heart Failure0104.nccdn.net/1_5/3ac/28b/021/HF-Blueprint-Guide-Final.pdf · Clinical Conditions & Symptom Management: Heart Failure VNAA

Critical Interventions/Actions – Initial Comprehensive Nursing Assessment

– OASIS & physical assessment w/emphasis on cardiovascular symptoms

– Nutritional assessment & BMI w/referral to dietician if 2 or more therapeutic diets

– Mental status/anxiety screening – Refer to MSW if more extensive psychosocial

evaluation needed

8

Page 9: Clinical Conditions & Symptom Management: Heart Failure0104.nccdn.net/1_5/3ac/28b/021/HF-Blueprint-Guide-Final.pdf · Clinical Conditions & Symptom Management: Heart Failure VNAA

Critical Interventions/Actions RN Assessment

– Activity tolerance w/referral to PT &/or OT – Learning ability/readiness using tool such as Confidence Ruler – Barriers to adherence – O2 safety & usage – Medication reconciliation – Pt. ability to teach-back signs & symptoms of worsening HF &

possession of hard copy list of signs, symptoms & actions to take

9

Page 10: Clinical Conditions & Symptom Management: Heart Failure0104.nccdn.net/1_5/3ac/28b/021/HF-Blueprint-Guide-Final.pdf · Clinical Conditions & Symptom Management: Heart Failure VNAA

Critical Interventions/Actions - Ongoing Care

• Visit frequency of SN &/or Rehab: 1-2 times/week. • Telehealth or Telephonic calls program remains in place • Assess with every visit:

– Vital signs – Cardiovascular assessment w/focus on HF signs & symptoms listed in

Blueprint – Request weight log to assess pt. ability to log daily weights – Pain status

10

Page 11: Clinical Conditions & Symptom Management: Heart Failure0104.nccdn.net/1_5/3ac/28b/021/HF-Blueprint-Guide-Final.pdf · Clinical Conditions & Symptom Management: Heart Failure VNAA

Assess With Every Visit – Nutrition – Mental status/anxiety/depression – Any falls since last visit – Changes in medication orders or usage – Pt knowledge of medications to avoid that exacerbate HF – Pt ability to manage co-morbid conditions (DM, COPD, depression) – Learning ability/readiness for change – Barriers to adherence – O2 saturation, safety & usage. – Advanced Planning & palliative care conversation if pt. appropriate

11

Page 12: Clinical Conditions & Symptom Management: Heart Failure0104.nccdn.net/1_5/3ac/28b/021/HF-Blueprint-Guide-Final.pdf · Clinical Conditions & Symptom Management: Heart Failure VNAA

Critical Interventions/Actions – Transition Care Planning

• Follow-up PCP visit scheduled • Continuing lab services arranged • Refer to private pay services & community resources as needed • Refer to Palliative care/Hospice services when indicated • Reconcile current medication list & hand off to next provider • Assure plan for med procurement & mgmt

12

Page 13: Clinical Conditions & Symptom Management: Heart Failure0104.nccdn.net/1_5/3ac/28b/021/HF-Blueprint-Guide-Final.pdf · Clinical Conditions & Symptom Management: Heart Failure VNAA

CRITICAL INTERVENTIONS/ACTIONS – TEACHING SELF CARE SKILLS

13

Page 14: Clinical Conditions & Symptom Management: Heart Failure0104.nccdn.net/1_5/3ac/28b/021/HF-Blueprint-Guide-Final.pdf · Clinical Conditions & Symptom Management: Heart Failure VNAA

Medication taking & management

Research has found Medication adherence a problem for many pts. with HF. Contributing factors include depression, cost, mild cognitive impairment, limited health literacy, attitudes about taking medicine, effect of certain medicines on sexual function, lack of understanding/confusing discharge instructions.

14

Page 15: Clinical Conditions & Symptom Management: Heart Failure0104.nccdn.net/1_5/3ac/28b/021/HF-Blueprint-Guide-Final.pdf · Clinical Conditions & Symptom Management: Heart Failure VNAA

Medication Taking

– Refer to MSW if cost or ability to obtain meds is problem – Assess/teach understanding of all med actions & side effects, – Work w/pt. to develop self-care behaviors including decisions & plans

to incorporate med taking into daily activities, obtaining initial & refill prescriptions, & managing a change of routine brought about by appointments, travel & other illnesses

– Refer to OT or ST if cognitive skills a barrier – Assess for need to obtain devices such as pill boxes

15

Page 16: Clinical Conditions & Symptom Management: Heart Failure0104.nccdn.net/1_5/3ac/28b/021/HF-Blueprint-Guide-Final.pdf · Clinical Conditions & Symptom Management: Heart Failure VNAA

Symptom Monitoring Research has demonstrated that pts. delay for days before seeking care for symptoms of HF. May be due to failure to routinely monitor symptoms or inability to recognize & interpret symptoms when they occur.

16

Page 17: Clinical Conditions & Symptom Management: Heart Failure0104.nccdn.net/1_5/3ac/28b/021/HF-Blueprint-Guide-Final.pdf · Clinical Conditions & Symptom Management: Heart Failure VNAA

Symptom Monitoring • Assess HF symptoms on each visit – vital signs, weight, dyspnea, lung

sounds, fatigue, appetite, peripheral & abdominal edema chest pain, SPO2, sleep disturbances, dry cough, activity tolerance, dehydration (orthostatic hypotension)

• Educate pts./caregivers to improve abilities to recognize, interpret & act on early symptoms (see tools). Use teach-back to assess learning

• Use Remote pt. Monitoring as tool for daily, repeated, serial assessments of specific symptoms

• Utilize Stoplight/Zone tools to help pts. interpret & act on symptom changes

• Help pt./caregiver to identify 1-2 achievable goals

17

Page 18: Clinical Conditions & Symptom Management: Heart Failure0104.nccdn.net/1_5/3ac/28b/021/HF-Blueprint-Guide-Final.pdf · Clinical Conditions & Symptom Management: Heart Failure VNAA

Sodium Restriction • ACCF/AHA Guidelines for Stages A & B HF recommend 1,500 mg/day. • ACCF/AHA Guidelines for Stages C & D HF state “Sodium restriction is

reasonable for pts. w/symptomatic HF to reduce congestive symptoms.” It is noted that sodium intake is high in general population, so some decrease in intake is appropriate.

18

Page 19: Clinical Conditions & Symptom Management: Heart Failure0104.nccdn.net/1_5/3ac/28b/021/HF-Blueprint-Guide-Final.pdf · Clinical Conditions & Symptom Management: Heart Failure VNAA

Sodium Restriction

– Obtain pt. specific sodium restriction orders from physician – Use evidence-based sodium teaching tools such as “Tips to Cut”

Sodium to encourage pts. to adhere to prescribed restriction – Use food from pt’s. cupboards to teach how to read labels. Evaluate

ability to read sodium content by having pt sort high & low sodium foods

– Educate aides assisting w/meal preparation – Consider administering Newest Vital Sign Tool

19

Page 20: Clinical Conditions & Symptom Management: Heart Failure0104.nccdn.net/1_5/3ac/28b/021/HF-Blueprint-Guide-Final.pdf · Clinical Conditions & Symptom Management: Heart Failure VNAA

Fluid Restriction Guidelines recommend fluid restriction <2 liters/day especially for pts w/severe hyponatremia or persistent or recurrent fluid retention despite sodium restriction & use of diuretics. Research has demonstrated that routine fluid restriction in pts w/mild to moderate symptoms does not confer clinical benefit.

– Obtain pt. specific fluid restriction orders from physician for appropriate pts.

– Use evidence-based teaching tools to encourage pts/caregivers to adhere to specific restrictions if ordered

– For pts. who are Stage D where referral to Palliative Care or Hospice may be appropriate, fluid restriction is not usually helpful

20

Page 21: Clinical Conditions & Symptom Management: Heart Failure0104.nccdn.net/1_5/3ac/28b/021/HF-Blueprint-Guide-Final.pdf · Clinical Conditions & Symptom Management: Heart Failure VNAA

Alcohol & Caffeine Consumption Current guidelines recommend limiting intake of alcohol to no more than 1-2 glasses (6-8 oz per glass) of wine/day, or no more than 2 glasses for men & 1 for women. Persons with alcoholic cardiomyopathy should not drink alcohol Moderate coffee consumption (1-2 cups per day) does not appear to be harmful.

– Ask about daily alcohol consumption when completing OASIS-C Risk Factor assessment

– Use consumption recommendations to provide more insight & dialog

21

Page 22: Clinical Conditions & Symptom Management: Heart Failure0104.nccdn.net/1_5/3ac/28b/021/HF-Blueprint-Guide-Final.pdf · Clinical Conditions & Symptom Management: Heart Failure VNAA

Weight Loss • Dieting may be potentially harmful in pts. with HF (Riegel, 2009). Obese

persons with HF have lower mortality & hospitalization rates than pts. with normal BMI.

• Conversely, weight loss may reflect cachexia, the clinically important & terminal phase of body wasting found as a complication of several chronic illnesses including HF.

• Consensus is that if BMI is >40 kg/m2, weight loss should be encouraged. If BMI is <30 kg/m2 weight loss should not be encouraged.

• No recommendations are made for persons with a BMI between 30-40 kg/m2.

22

Page 23: Clinical Conditions & Symptom Management: Heart Failure0104.nccdn.net/1_5/3ac/28b/021/HF-Blueprint-Guide-Final.pdf · Clinical Conditions & Symptom Management: Heart Failure VNAA

Weight Loss

– Teach pts. to monitor for loss of appetite, – Teach pts. to limit saturated fat, transfats & simple

carbohydrates – Determine dietary advice based on BMI (see

above) – Use the MyPlate Method for teaching appropriate

dietary intake – Because weight loss is a powerful independent

variable that predicts mortality discussion of advanced care planning &/or hospice referral should be initiated with pts. who are cachectic

23

Page 24: Clinical Conditions & Symptom Management: Heart Failure0104.nccdn.net/1_5/3ac/28b/021/HF-Blueprint-Guide-Final.pdf · Clinical Conditions & Symptom Management: Heart Failure VNAA

Physical Activity • Routine exercise is a potent way to improve oxygen delivery & decrease

inflammation w/in the arterial wall. • Exercise is recommended in pts. w/current or prior symptoms of HF &

reduced LV ejection fraction. • Few persons w/HF report engaging in exercise. • No universal prescription exists, however, guidelines suggested sustained

aerobic activity for 20-30 minutes, 3-5 times/week should be a goal.

24

Page 25: Clinical Conditions & Symptom Management: Heart Failure0104.nccdn.net/1_5/3ac/28b/021/HF-Blueprint-Guide-Final.pdf · Clinical Conditions & Symptom Management: Heart Failure VNAA

Physical Activity

– Discuss physical activity program & goals w/physician & pt. – Refer to PT to establish exercise regimen to improve strength, duration

& safety – Refer to OT for energy conservation techniques & adaptive equipment – Utilize modified BORG scale for perceived exertion. AHA

recommendation for pts. w/heart disease is to use a Borg score & maintain activity level between 13-15 on scale

– Teach simple exercises for limited mobility pts. – Consider referral to an outpt. cardiac rehabilitation program

25

Page 26: Clinical Conditions & Symptom Management: Heart Failure0104.nccdn.net/1_5/3ac/28b/021/HF-Blueprint-Guide-Final.pdf · Clinical Conditions & Symptom Management: Heart Failure VNAA

Smoking Cessation Tobacco use is strongly associated with risk for increased incident of HF. Nicotine replacement therapy & antidepressants are recommended to help HF Pts to quit smoking.

– Address smoking at SOC & ROC & throughout the episode – Communicate with physician on pt’s. readiness to quite smoking – Utilize resources such as “Drug Interactions with Tobacco Smoke” – Determine which of the many FREE programs clinicians can use w/pts.

To be effective, on-going coaching support is needed

26

Page 27: Clinical Conditions & Symptom Management: Heart Failure0104.nccdn.net/1_5/3ac/28b/021/HF-Blueprint-Guide-Final.pdf · Clinical Conditions & Symptom Management: Heart Failure VNAA

Preventive Behaviors Routine hand washing, dental health, & maintenance of scheduled immunizations may limit inflammation & infection, which can cause tissue ischemia in persons with HF.

– Work to motivate pts. to actively participate in self-care; to be able to associate dental health, prevention of flu & pneumonia, & symptom monitoring w/prevention of hospitalization and slowing of disease process.

– Document flu & pneumonia vaccine status on OASIS

27

Page 28: Clinical Conditions & Symptom Management: Heart Failure0104.nccdn.net/1_5/3ac/28b/021/HF-Blueprint-Guide-Final.pdf · Clinical Conditions & Symptom Management: Heart Failure VNAA

Nonprescription Medications Pts. often unaware of possible interactions w/HF therapies & seldom inform their physicians they’re using herbal remedies, alternative medicines & other OTC drugs. • Ask pts. regarding use of alternative & complementary therapies • Teach pts. to maintain written record of all medications they’re taking

including OTC & herbal supplements • NSAIDS such as ibuprofen, indomethacin & naproxen aren’t recommended

in pts. w/chronic HF

28

Page 29: Clinical Conditions & Symptom Management: Heart Failure0104.nccdn.net/1_5/3ac/28b/021/HF-Blueprint-Guide-Final.pdf · Clinical Conditions & Symptom Management: Heart Failure VNAA

Important Co-Morbidities Many pts. w/HF have more than 1 co-morbidity. ACCF/AHA Heart Failure Guidelines (2013) list among the top 10 most common among Medicare beneficiaries w/HF as: Hypertension, Ischemic Heart Disease, Hyperlipidemia, and Diabetes. • Educate regarding importance of reducing lipids to goal • Teach pt. need to keep blood pressure at goal to help slow progression of

disease • Work w/pt. who is also diabetic to understand need to keep HGA1C at goal

29

Page 30: Clinical Conditions & Symptom Management: Heart Failure0104.nccdn.net/1_5/3ac/28b/021/HF-Blueprint-Guide-Final.pdf · Clinical Conditions & Symptom Management: Heart Failure VNAA

Pharmacologic Treatment of HF • Angiotensin-Converting Enzyme Inhibitors (ACEI) • Angiotensin Receptor Blocks (ARB) • Beta Adrenergic Blockers • Aldosterone Antagonists • Diuretics • Combination vasodilators • Other

30

Page 31: Clinical Conditions & Symptom Management: Heart Failure0104.nccdn.net/1_5/3ac/28b/021/HF-Blueprint-Guide-Final.pdf · Clinical Conditions & Symptom Management: Heart Failure VNAA

Symptom Measurement Tools • Self-management includes recognizing the signs that a condition may be

worsening. • Staff should help pts. & caregivers identify & manage changes in pt’s.

symptoms & recognize “red flags” that indicate potential deterioration. • Tools identified in the VNAA HF Blueprint can help achieve this goal.

31

Page 32: Clinical Conditions & Symptom Management: Heart Failure0104.nccdn.net/1_5/3ac/28b/021/HF-Blueprint-Guide-Final.pdf · Clinical Conditions & Symptom Management: Heart Failure VNAA

OASIS Outcome & Process Measures for Assessing Impact of HF Program

• M1400 – When is the pt. dyspneic or noticeably short of breath – outcome measure

• M1242 – Frequency of pain interfering w/activity or movement – outcome measure

• M1720 – When is the pt. anxious (reported or observed in last 14 days) – outcome measure

• M1730 – Depression Screening – process measure • M2000 - Drug regimen review – process measure • M2002 – Medication follow-up – process measure • M2020 – Management of Oral medications – outcome measure

32

Page 33: Clinical Conditions & Symptom Management: Heart Failure0104.nccdn.net/1_5/3ac/28b/021/HF-Blueprint-Guide-Final.pdf · Clinical Conditions & Symptom Management: Heart Failure VNAA

Home Care Pt/Caregiver Outcomes for Assessing Impact of HF program

• Pt./caregiver demonstrates ability to take medications correctly (OASIS) • Pt./caregiver able to verbalize medication actions, what to expect,

administration schedule & side effects to report • Pt./caregiver able to verbalize understanding of weight gain parameters &

weigh self daily • Pt./caregiver able to verbalize signs & symptoms of worsening heart

failure & promptly report to physician

33

Page 34: Clinical Conditions & Symptom Management: Heart Failure0104.nccdn.net/1_5/3ac/28b/021/HF-Blueprint-Guide-Final.pdf · Clinical Conditions & Symptom Management: Heart Failure VNAA

Pt/Caregiver Outcomes • Pt./caregivers demonstrate healthy meal planning • Pt./caregivers demonstrate progressive

independence in self-care mgmt. of care needs • Pt. maintains daily record of fatigue, dyspnea –

other symptoms individualized to pt. & demonstrates appropriate interventions

• Pt. participates in exercise program of at least 30 minutes of aerobic exercise 3 times/week

• Pt. has received flu & pneumonia immunizations

34

Page 35: Clinical Conditions & Symptom Management: Heart Failure0104.nccdn.net/1_5/3ac/28b/021/HF-Blueprint-Guide-Final.pdf · Clinical Conditions & Symptom Management: Heart Failure VNAA

Pt/Caregiver Outcomes • Pt. maintains Personal Health Record & reviews it w/each physician at

each appt. • Pt./caregiver able to state signs of HF exacerbation • Pt./caregivers demonstrate understanding of chronic nature of condition

& preventative measures to minimize risks of exacerbation • "Advanced Planning & Palliative Care" conversation has occurred w/all pts.

as appropriate & w/all pts. who have had more than 3 hospitalizations in 6 months

35

Page 36: Clinical Conditions & Symptom Management: Heart Failure0104.nccdn.net/1_5/3ac/28b/021/HF-Blueprint-Guide-Final.pdf · Clinical Conditions & Symptom Management: Heart Failure VNAA

References & Resources

• Refer to www.VNAABlueprint.org Home Health, Clinical Conditions, HF

36